Effects of Atorvastatin in Graves' Orbitopathy (GO)

NCT03110848 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Thyroid Associated Ophthalmopathy
Hypercholesterolemia

Interventions

DRUG: Atorvastatin
DRUG: Methylprednisolone

Sponsor

University of Pisa